Rethinking the rabies vaccine
A new high-resolution structure of the rabies virus glycoprotein reveals potential vaccine targets. …
A new high-resolution structure of the rabies virus glycoprotein reveals potential vaccine targets. …
Study provides the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2. …
A genetic signature has been identified in memory T cells of Parkinson’s disease patients, suggesting potential therapeutic targets to stop autoimmune attacks on brain cells. …
A cocktail of two monoclonal antibodies completely protects nonhuman primates from Ebola virus and Sudan virus infections. …
Four COVID-19 vaccines (Pfizer-BioNTech, Moderna, J&J/Janssen, and Novavax) prompt the body to make effective, long-lasting T cells against SARS-CoV-2, including the Delta and Omicron variants. …
Scientists have found they can dramatically improve survival of mice with cystic fibrosis through a partial bone marrow transplant. …
Macrophages can sniff out octanal in blood, triggering dangerous inflammation and atherosclerosis. …
New findings show how genetic variations linked to severe COVID-19 affect our immune cells. …
A new study helps answer the question: how long does immunity against COVID-19 last in vaccinated people? …
Whole-genome analysis reveals essential roles of vitamin C and TET enzymes in generating stable regulatory T cells (Tregs). …
End of content
End of content